New Application of Viable PCR for Following Early Tuberculosis Treatment
Italian researchers from San Raffaele Scientific Institute,(Milan) report an innovative approach to selectively amplify DNA derived from viable Mycobacterium tuberculosis in clinical specimens, which is useful for monitoring mycobacterial load in pulmonary TB patients during anti-TB treatment.
The procedure is based in a sample pre treatment with PMA (500uM, 30 min a 4ºC in the dark ) and 15 min of photo activation with a Geniul system. Please click here for further information.
Tags: Mycobacterium, PCR, Mycobacterium tuberculosis
Date Published: May 21, 2012
Source article link: GENIUL, S.L. » company contact details
Bio-Rad Launches a New PCR Kit and Chromogenic Media
Go Beyond TaqMan Specificity - Gain Additional Control With Less Work
Detection of Genetically Modified Salmon in Food and Feed
High-Throughput Solution for Automated DNA/RNA Extraction and PCR Setup
Efficient and Reliable Detection of Beer Spoiling Bacteria in Just an Hour!